
|Articles|October 1, 2016
- Applied Clinical Trials-10-01-2016
- Volume 25
- Issue 10
Applied Clinical Trials, October/November 2016 Issue (PDF)
Click the title above to open the Applied Clinical Trials October/November 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
PDUFA VI Promotes Patient Views, Innovative Trialsabout 9 years ago
Health Technology Assessment: Europe Peers Into the Mistabout 9 years ago
Europe’s New Clinical Trials Landscape Looms Largeabout 9 years ago
Best Practices in Study Feasibilityabout 9 years ago
FDA Includes First PRO Measure for COPDabout 9 years ago
The Growth of Direct-to-Patient Trialsabout 9 years ago
It’s Never Too Early for Cold Chain Planning for Cell Therapiesabout 9 years ago
Finally, Standardized KPIs are Front and Centerabout 9 years ago
Assessing Global Clinical Supply Logisticsabout 9 years ago
6 Ways to Protect the Blind in Clinical TrialsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Honing the Power of AI for Next Generation Trial Oversight and Execution
2
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
3
The Value of Pragmatic Randomized Clinical Trials: Strategic Approaches for Real-World Impact
4
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
5